Showing 14,341 - 14,360 results of 27,685 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (we decrease)) ))', query time: 0.95s Refine Results
  1. 14341
  2. 14342

    Supplementary file 1_Influence of circadian rhythm on the determination of the IMMune age indeX (IMMAX).docx by Sina Trebing (22578458)

    Published 2025
    “…</p>Methods<p>Therefore, we conducted an experimental study with 50 participants aged 20–69 years and took blood samples at 8 a.m., 1 p.m. and 6 p.m. to determine the IMMAX over the day. …”
  3. 14343
  4. 14344
  5. 14345
  6. 14346
  7. 14347

    Quantification and analysis of the RNAi mediated by synthetic siRNAs targeting over 100 human genes by Scott E. Martin (30985)

    Published 2011
    “…Data is shown as the mean percentage decrease in target mRNA levels observed for four independent parallel transfections (plus SD). …”
  8. 14348

    Growth states before drug exposure affect survival. by Akihisa Seita (10063260)

    Published 2021
    “…<p>(A) Decrease of division rate upon drug exposure. …”
  9. 14349
  10. 14350
  11. 14351
  12. 14352
  13. 14353

    SU86.86 cells exhibit phenotypic and genotypic changes following selection by IH. by Daniel Verduzco (712932)

    Published 2015
    “…A significant decrease in expression of E-cadherin (A) and p53 (B) was detected by quantitative Real-Time PCR. …”
  14. 14354
  15. 14355
  16. 14356
  17. 14357
  18. 14358

    ELMO1 Is Upregulated in AML CD34+ Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML by Marta E. Capala (652765)

    Published 2014
    “…Finally, ELMO1 depletion caused a marked decrease in SDF1-induced chemotaxis of leukemic cells. …”
  19. 14359

    Effect of Cantide treatments on growth of HLBL-0102 PHL. by Bo Yang (104813)

    Published 2013
    “…</b> (D) Determination of serum LDH activity in Cantide-treated HLBL-0102 mice. There was a dose-dependent decrease in LDH activity in Cantide-treated mice. …”
  20. 14360

    datasheet1_COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments.docx by Natalia Soldevila-Domenech (9903768)

    Published 2020
    “…Our results report a decreased incidence of COVID-19 in patients receiving specific DMARDs with different immunodepressor mechanisms with striking sex differences. …”